| Today's Open | $5.46 |
|---|---|
| Previous Close | $5.39 |
| Daily Range | $5.45 - $5.73 |
| 52-Week Range | $5.00 - $12.98 |
| Market Cap | $274.0M |
| P/E Ratio | -5.28 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 509,494 |
| Average Daily Volume | 606,728 |
| Current FY EPS | -$1.90 |
Sector
Healthcare
Industry
Drugs
XenoPort, Inc. (XNPT) Description
A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. Website: http://www.xenoport.com/
News & Commentary
XenoPort writes the wrong prescription for shareholders when it announced top-line data for a late-stage clinical trial.
XNPT's Top Competitors
(7.24%)
(-0.42%)
(0.62%)
(0.53%)